Pith. sign in

REVIEW 1 cited by

Precise Antigen-Antibody Structure Predictions Enhance Antibody Development with HelixFold-Multimer

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2412.09826 v1 pith:D4OJH6WR submitted 2024-12-13 q-bio.BM cs.AIcs.CEcs.LG

classification q-bio.BMcs.AIcs.CEcs.LG
keywords antigen-antibodyhelixfold-multimerantibodydevelopmenttherapeuticessentialimprovedmodels
verification ladder T0 review T1 audit T2 compute T3 formal
0 comments
read the original abstract

The accurate prediction of antigen-antibody structures is essential for advancing immunology and therapeutic development, as it helps elucidate molecular interactions that underlie immune responses. Despite recent progress with deep learning models like AlphaFold and RoseTTAFold, accurately modeling antigen-antibody complexes remains a challenge due to their unique evolutionary characteristics. HelixFold-Multimer, a specialized model developed for this purpose, builds on the framework of AlphaFold-Multimer and demonstrates improved precision for antigen-antibody structures. HelixFold-Multimer not only surpasses other models in accuracy but also provides essential insights into antibody development, enabling more precise identification of binding sites, improved interaction prediction, and enhanced design of therapeutic antibodies. These advances underscore HelixFold-Multimer's potential in supporting antibody research and therapeutic innovation.

Discussion (0). Continue with ORCID to comment.

Forward citations

Cited by 1 Pith paper

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. Full citation record

  1. HelixDesign-Antibody: A Scalable Production-Grade Platform for Antibody Design Built on HelixFold3

    q-bio.BM 2025-07 reject novelty 4.0 of 10

    The paper describes a production antibody design platform built on HelixFold3 and reports that sampling more candidates improves top-ranked metrics, a claim that reduces to trivial sampling statistics.

Pith tools